Sensory,
Teleoperated,
Intuitive
Teleoperated,
Intuitive
The first fully-robotic
teleoperated system
for endovascular interventions
Sentante
Endovascular procedures performed remotely with uncompromised feedback force
View Video
3:00
Sentante enables the remote manipulation of catheters and guidewires
for safe and rapid endovascular disease management
Remote interventions reduce the response time for
stroke, heart attack
and bleeding
Uniqueness
of Sentante:
of Sentante:
Disruptive technology:
01
Fully robotic
The manipulation of three endovascular instruments simultaneously allows the entire procedure to be performed robotically.
02
Teleoperated
The endovascular procedure can be performed from a different room or hospital.
03
Haptic feedback
Physicians can feel the catheter and guidewire just as if they were standing near the patient
04
Universal compatibility
A variety of dedicated catheters and guidewires are compatible, with no dependence on the manufacturer
05
Precise manipulation
Accurate, submillimetric instrument positioning and stent placement
06
Ergonomic workplace
Allows physicians to fully concentrate on an ongoing case without the use of heavy lead aprons
07
No additional training is needed
Physicians interface with the robot is via the same endovascular instruments as in a manual procedure
08
Occupational hazards free
Medical personnel are not exposed to hazardous X-rays
Future
perspectives
perspectives
01
Training module
Realistic training platform with haptic feedback for residents and new physicians
02
Device testing platform
Simulated models for safe, affordable testing and training of endovascular devices
03
Artificial intelligence based automation
Semi-automated routine tasks such as catheter or guidewire exchange
About Us
Our vision is to transform healthcare by increasing treatment availability for patients and protecting medical personnel from occupational hazard. Our mission is to bring the world’s first fully-robotic system for endovascular interventions to clinical practice for the benefit of patients, physicians, and hospitals.
Our values People focused. We care about patients, medical personnel, and colleagues. Result-based. We are bringing only evidence-based, new medical solutions to the hospitals.
Innovation driven. Constant research and development of the novel medical solutions. Sustainability in mind. Trying not to destroy the planet while supplying the most advanced healthcare solutions.
Our vision is to transform healthcare by increasing treatment availability for patients and protecting medical personnel from occupational hazard. Our mission is to bring the world’s first fully-robotic system for endovascular interventions to clinical practice for the benefit of patients, physicians, and hospitals.
Our values People focused. We care about patients, medical personnel, and colleagues. Result-based. We are bringing only evidence-based, new medical solutions to the hospitals.
Innovation driven. Constant research and development of the novel medical solutions. Sustainability in mind. Trying not to destroy the planet while supplying the most advanced healthcare solutions.
Management Team
Advisory Board Members
Edvardas Satkauskas
CEO
Dr. Tomas Baltrūnas
CMO
Dr. Evaldas Kalvaitis
Supply Chain Officer
Vilius Dambrauskas
CTO
Paulius Dambrauskas
Head of QARA
Dr. Leona Damalakienė
Head of Clinical Affairs
Ugnė Gurskė
Head of HR
Dr. Ricardo A. Hanel
Medical Advisory Board Member
![bandymas4[4382]](https://sentante.com/wp-content/uploads/elementor/thumbs/bandymas44382-q4uru2vgjr8kaa9e5haw4af639rkgxg1vvurfx2xi8.png "bandymas4[4382]")
Dr. Michael Lichtenberg
Medical Advisory Board Member
![David-Liebeskind[4385]](https://sentante.com/wp-content/uploads/elementor/thumbs/David-Liebeskind4385-q4usqcnz6zeywbdtpfhrq58wbip8qtkabm6wlx8bvk.png "David-Liebeskind[4385]")
Dr. David Liebeskind
Medical Advisory Board Member
![Giovanni-gera[4434]](https://sentante.com/wp-content/uploads/elementor/thumbs/Giovanni-gera4434-q4uw1a6txc81w4mo8c7epmti5mi5o4pn09rllaw2lc.png "Giovanni-gera[4434]")
Dr. Giovanni Torsello
Medical Advisory Board Member
![Peter-Shneider[4388]](https://sentante.com/wp-content/uploads/elementor/thumbs/Peter-Shneider4388-q4ussc3pme4reoi24adezn7xgsx4ztfvxfrt2yaeqo.png "Peter-Shneider[4388]")
Dr. Peter Schneider
Medical Advisory Board Member
Matt Lemay
Business Advisory Board Member
Christopher Prentice
Business Advisory Board Member
Route to
market
market
Expecting launch in 2026
01
Inovatyvi Medicina established
Sentante development began
02
First grant received
Lithuanian Business support agency
01
Hard, dedicated work
TRL4 reached
02
H2020 SME phI grant
Awarded a highly competitive grant
03
Perfect New Year’s party
A solid kickstart into 2019
01
First animal test
Proved to manipulate guidewires perfectly
02
TRL4 reached
Positive feedback from physicians
01
Ongoing animal tests
Again, proved to manipulate guidewires and catheters perfectly
02
TRL5 reached
03
First patent application
EPO
01
TRL6 reached
02
Successful stent implantation
Both Rx and OTW
03
First patent application
01
Work in progress
01
Pre-clinical animal testing
02
Continuing patent applications
01
First use of the Sentante robotic system in human patients
01
First fully robotic remote endovascular stroke thrombectomy
